Autopsy report · NCT05003921

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for ALS

“Inability to recruit patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

The Foundation for Orthopaedics and Regenerative Medicine

Sponsor type

University, hospital or other

Conditions

Amyotrophic Lateral Sclerosis

Interventions

cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells

Participants

0

Trials that died the same way

• Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial
  “inability to recruit more patients” (95% match in meaning)
• Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
  “difficult to recruit patients” (92% match in meaning)
• Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
  “not able to recruit patients” (89% match in meaning)
• Does Thiamine Help Vomiting and Nausea in Pregnancy?
  “Difficulties in recruiting patients” (88% match in meaning)
• Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases
  “Difficulties surrounding recruiting patients” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.